US Patent Issued to GENMAB HOLDING on April 15 for "Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof" (Dutch, American Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,797, issued on April 15, was assigned to GENMAB HOLDING B.V. (Utrecht, Netherlands).

"Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof" was invented by Simone Oostindie (Utrecht, Netherlands), Frank Beurskens (Utrecht, Netherlands), Ronald Taylor (Keswick, Va.), Margaret Lindorfer (Keswick, Va.), Hilma Van Der Horst (Utrecht, Netherlands), Martine E. D. Chamuleau (Amsterdam), Tuna Mutis (Amsterdam), Paul Parren (Odijk, Netherlands) and Esther Breij (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-CD37antibodies having an Fc-Fc interaction enhancing substit...